Follow-The-Filings

Security · featured owners

RLMD Relmada Therapeutics Inc.

COM Equity as of 2026 Q2 among managers we track

  • 1 Owner
  • Max 0.6%
  • $6M

Who owns this now

Largest portfolio weights among featured holders · max 0.6% (James Silverman - Opaleye Management) · not free-float ownership

  1. James Silverman 0.59%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
James Silverman - Opaleye Management 2026 Q2 0.59% Hold 935,000 $6M history

1 current · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Net income -$98.79M -$79.98M -$57.39M

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $97.51M $45.8M $93.98M
Total non-current assets * $43,125 $21,975 $19,500
Total assets $97.55M $45.82M $94M
Total current liabilities $12.19M $10.29M $6.43M
Total non-current liabilities * $0M $0.004M $1.06M
Total equity $85.36M $35.52M $86.51M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$51.66M -$51.76M -$45.79M
Cash from investing $50.45M $51.56M -$48.14M
Cash from financing -$0.098M -$0.04M $93.56M
Net change in cash * -$1.3M -$0.235M -$0.36M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders